136 related articles for article (PubMed ID: 15113585)
1. Effect of probucol on the oral bioavailability of cyclosporine A.
Sugimoto K; Sudoh T; Tsuruoka S; Yamamoto Y; Maezono S; Watanabe Y; Fujimura A
Eur J Pharm Sci; 2004 May; 22(1):71-7. PubMed ID: 15113585
[TBL] [Abstract][Full Text] [Related]
2. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
Song KH; Fasano A; Eddington ND
Int J Pharm; 2008 Mar; 351(1-2):8-14. PubMed ID: 17954018
[TBL] [Abstract][Full Text] [Related]
3. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.
Ikemura K; Urano K; Matsuda H; Mizutani H; Iwamoto T; Okuda M
J Pharmacol Exp Ther; 2009 Jan; 328(1):249-55. PubMed ID: 18842703
[TBL] [Abstract][Full Text] [Related]
4. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
[TBL] [Abstract][Full Text] [Related]
5. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
Arima H; Yunomae K; Hirayama F; Uekama K
J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
[TBL] [Abstract][Full Text] [Related]
6. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
[TBL] [Abstract][Full Text] [Related]
7. Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats.
Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
J Pharm Pharmacol; 2004 Oct; 56(10):1259-66. PubMed ID: 15482640
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of docosahexaenoic acid as a bioavailability enhancer for CYP3A substrates: in vitro and in vivo evidence using cyclosporin in rats.
Hirunpanich V; Katagi J; Sethabouppha B; Sato H
Drug Metab Dispos; 2006 Feb; 34(2):305-10. PubMed ID: 16299163
[TBL] [Abstract][Full Text] [Related]
9. Decrease in oral bioavailability of cyclosporin A by coadministration of probucol in rats.
Sugimoto K; Sakamoto K; Fujimura A
Life Sci; 1997; 60(3):173-9. PubMed ID: 9000641
[TBL] [Abstract][Full Text] [Related]
10. [The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats].
Liu XL; Tang J; Song J; He J; Xu P; Peng WX
Yao Xue Xue Bao; 2006 Sep; 41(9):882-7. PubMed ID: 17111838
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the intestinal permeability of ciclosporin using the in situ technique in rats and the relevance of P-glycoprotein.
Zakeri-Milani P; Valizadeh H; Islambulchilar Z; Damani S; Mehtari M
Arzneimittelforschung; 2008; 58(4):188-92. PubMed ID: 18540481
[TBL] [Abstract][Full Text] [Related]
12. An antioxidant Trolox restores decreased oral absorption of cyclosporine A after liver ischemia-reperfusion through distinct mechanisms between CYP3A and P-glycoprotein in the small intestine.
Ikemura K; Inoue K; Mizutani H; Oka H; Iwamoto T; Okuda M
Eur J Pharmacol; 2012 Sep; 690(1-3):192-201. PubMed ID: 22749977
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus oral absorption in rats is increased by ketoconazole but is not affected by D-alpha-tocopheryl poly(ethylene glycol 1000) succinate.
Wacher VJ; Silverman JA; Wong S; Tran-Tau P; Chan AO; Chai A; Yu XQ; O'Mahony D; Ramtoola Z
J Pharmacol Exp Ther; 2002 Oct; 303(1):308-13. PubMed ID: 12235265
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state.
Nielsen FS; Petersen KB; Müllertz A
Eur J Pharm Biopharm; 2008 Jun; 69(2):553-62. PubMed ID: 18294829
[TBL] [Abstract][Full Text] [Related]
15. Supersaturated polymeric micelles for oral cyclosporine A delivery.
Yu H; Xia D; Zhu Q; Zhu C; Chen D; Gan Y
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1325-36. PubMed ID: 23954511
[TBL] [Abstract][Full Text] [Related]
16. Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data.
Hsiao P; Sasongko L; Link JM; Mankoff DA; Muzi M; Collier AC; Unadkat JD
J Pharmacol Exp Ther; 2006 May; 317(2):704-10. PubMed ID: 16415090
[TBL] [Abstract][Full Text] [Related]
17. Pre-clinical evidence of enhanced oral bioavailability of the P-glycoprotein substrate talinolol in combination with morin.
Pathak SM; Udupa N
Biopharm Drug Dispos; 2010 Mar; 31(2-3):202-14. PubMed ID: 20238375
[TBL] [Abstract][Full Text] [Related]
18. Effect of atropine on gastrointestinal motility and the bioavailability of cyclosporine A in rats.
Quijano RF; Ohnishi N; Umeda K; Komada F; Iwakawa S; Okumura K
Drug Metab Dispos; 1993; 21(1):141-3. PubMed ID: 8095208
[TBL] [Abstract][Full Text] [Related]
19. Effects of tauroursodeoxycholate solutions on cyclosporin A bioavailability in rats.
Balandraud-Pieri N; Queneau PE; Caroli-Bosc FX; Bertault-Pérès P; Montet AM; Durand A; Montet JC
Drug Metab Dispos; 1997 Aug; 25(8):912-6. PubMed ID: 9280397
[TBL] [Abstract][Full Text] [Related]
20. Effect of imatinib mesilate on the disposition kinetics of ciclosporin in rats.
Kajita T; Higashi Y; Imamura M; Maida C; Fujii Y; Yamamoto I; Miyamoto E
J Pharm Pharmacol; 2006 Jul; 58(7):997-1000. PubMed ID: 16805961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
